Abstract
To evaluate the prevalence of depression in outpatients with type 2 diabetes and its possible correlation with anxiety, cognitive function, and clinical variables. The Zung Self-Rating Depression and Anxiety Scales and the Mini-Mental-State Examination were administered to 249 non-insulin-treated (NIT) and 249 insulin-treated (IT) outpatients with type 2 diabetes, aged 40–80, in a cross-sectional survey. Compared with a reported prevalence of 6–13% in the general population, 104 (20.9%) patients had either a score indicative of depression or were on anti-depressant medication. Assuming that medication might modify the responses to questionnaires, the latter patients were excluded from further analysis. IT patients had higher age, known duration of diabetes, HbA1c, more foot ulcers, retinopathy, microalbuminuria and practised more self-monitoring of blood glucose (P < 0.01 all) but a slightly lower mean depression score (P = 0.004) and similar anxiety or cognitive function. At multivariate analysis, depression was associated with anxiety (P < 0.001), age (P < 0.001), gender (men having lower scores than women, P = 0.042), and insulin treatment, IT patients being less depressed than NIT (P < 0.001), but none of the clinical variables. Anxiety correlated with age (P < 0.001). The association between depression and anxiety became progressively weaker with increasing age. These data confirm increased prevalence of depression in a population of patients with type 2 diabetes who did not show impaired cognitive function. The lack of correlation with disease duration, metabolic control, and complications suggests that depression may not appear/worsen with diabetes and/or its complications but rather supports suggestions that it might predate both.
Similar content being viewed by others
References
Lustman PJ, Anderson RJ, Freedland KE, deGroot M, Carney RM, Clouse RE (2000) Depression and poor glycaemic control: a meta-analytic review of the literature. Diabetes Care 23:934–942
Ciechanowski PS, Katon WJ, Russo JE (2000) Depression and diabetes: impact of depressive symptoms on adherence, function and costs. Arch Intern Med 160:3278–3285
Furuya M, Hayashino Y, Tsujii S, Ishii H, Fukuhara S (2010) Comparative validity of the WHO-5 well-being index and two-question instrument for screening depressive symptoms in patients with type 2 diabetes. Acta Diabetol. Aug 27. [Epub ahead of print] PubMed PMID: 20798962
Gois CJ, Ferro AC, Santos AL, Sousa FP, Ouakinin SR, do Carmo I, Barbosa AF (2010) Psychological adjustment to diabetes mellitus: highlighting self-integration and self-regulation. Acta Diabetol. [Epub ahead of print] PubMed PMID: 20473694
Gonzalez JS, Peyrot M, McCarl LA, Collins EM, Serpa L, Mimiaga MJ et al (2008) Depression and diabetes treatment non adherence: a meta-analysis. Diabetes Care 31:2398–2403
Rubin RR, Peyrot M (2001) Psychological issues, treatments for people with diabetes. J Clin Psychol 57:457–478
Lustman P, Clouse R (2005) Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complicat 19:113–122
Carnethon MR, Kinder LS, Fair JM, Stafford RS, Fortmann SP (2003) Symptoms of depression as a risk factor for incident diabetes: findings from the National Health and Nutrition Examination Epidemiologic Follow-up Study, 1971–1992. Am J Epidemiol 158:416–423
Mezuk B, Eaton WW, Albrecht S, Golden SH (2009) Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 32:2383–2390
Cukierman-Yaffe T, Gerstein HC, Anderson C et al (2009) Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programme. Diabetes Res Clin Pract 83:387–393
Kodl CT, Seaquist ER (2008) Cognitive dysfunction and diabetes mellitus. Endocr Rev 29:494–511
Zung WW (1965) A self-rating depression scale. Arch Gen Psychiatry 12:63–70
Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state: a practical method for grading the state of patients for the clinician. J Psychiatr Res 12:189–198
Blumenthal MD, Dielman TE (1975) Depressive symptomatology and role function in a general population. Arch Gen Psychiatry 32:985–991
Zung WW, King RE (1983) Identification and treatment of masked depression in a general medical practice. J Clin Psychiatry 44:365–368
Rajala U, Uusimäki A, Keinänen-Kiukaanniemi S, Kivelä SL (1994) Prevalence of depression in a 55-year-old Finnish population. Soc Psychiatry Psychiatr Epidemiol 29:126–130
Pergami A, Gala C, Burgess A, Invernizzi G, Catalan J (1994) Heterosexuals and HIV disease: a controlled investigation into the psychosocial factors associated with psychiatric morbidity. J Psychosomatic Res 4:305–313
Kamphuis MH, Geerlings MI, Dekker JM, Giampaoli S, Nissinen A, Grobbee DE, Kromhout D (2007) Autonomic dysfunction: a link between depression and cardiovascular mortality? The FINE Study. Eur J Cardiovasc Prev Rehabil 14:796–802
Kessler RC, ChiuW Tat, Demler O, Walters EE (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 62:617–627
Zung WW (1986) Prevalence of clinically significant anxiety in a family practice setting. Am J Psychiatry 143:1471–1472
Strine T, Mokdad A, Dube S, Balluz L, Gonzalez O, Berry J et al (2008) The association of depression and anxiety with obesity and unhealthy behaviors among community-dwelling US adults. Gen Hosp Psychiatry 30:127–137
Cox DJ, McCall A, Kovatchev B, Sarwat S, Ilag LL, Tan MH (2007) Effects of blood glucose rate of changes on perceived mood and cognitive symptoms in insulin-treated type 2 diabetes. Diabetes Care 30:2001–2002
Koopmas B, Pouwer F, de Bie RA, Leusink GL, Denollet JKL, Pop VJM (2009) Associations between vascular co-morbidities and depression in insulin-naïve diabetes patients: the DIAZOB Primary Care Diabetes Study. Diabetologia 52:2056–2063
Fal AM, Jankowska B, Uchmanowicz I, Sen M, Panaszek B, Polanski J (2010) Type 2 diabetes quality of life in patients treated with insulin and oral hypoglycemic medication. Acta Diabetol. Published online 30 December 2010. doi:10.1007/s00592-010-0244-y
van den Berg, Reijmer YD, de Bresser J, Kessels RPC, Kappelle LJ, Biessels GJ, on behalf of the Utrecht Diabetic Encephalopathy Study Group (2010) A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia 53:58–65
Acknowledgments
The work described in this paper was supported by funds from University of Turin (fondi ex-60%) and Ricerca Sanitaria Finalizzata Regione Piemonte.
Conflict of interests
No potential conflict of interest relevant to this article was reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Trento, M., Raballo, M., Trevisan, M. et al. A cross-sectional survey of depression, anxiety, and cognitive function in patients with type 2 diabetes. Acta Diabetol 49, 199–203 (2012). https://doi.org/10.1007/s00592-011-0275-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-011-0275-z